UK's NICE backs wider use of BMS, Pfizer anti-clot drug

move, saying it "confirms the value of apixaban as a cost-effective oral anticoagulant".

Ads by Google

Single Page Format

   Previous | 1 | 2

Previous Story  US debt limit vote set for Wed, Barack Obama likely to sign Next Story  Bharti Airtel and Idea Cellular raise mobile phone rates

Reader's Comments| Post a Comment

Be the first to comment.

Post your Comment

Your email address will not be published. Required fields are marked *

Name *

Email *

Message *

 

please enter the above characters in the box below